Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gentel Biosciences and RayBiotech have partnered to develop and market RayBiotech’s collection of antibody array products covering a variety of cytokines and other proteins for use with Gentel's APiX chromogenic detection platform.
Subscribe to our email newsletter
The new kits are a combination of Gentel’s APiX chromogenic detection technology and RayBiotech, collection of more than 55 antibody and protein arrays on a glass-slide format and each kit is configured for use with the Gentel Proteomics Multi-System and Gentel’s AthenaQuant analysis software as an alternative to fluorescent-based detection, the companies said.
Gentel claimed that APiX chromogenic technology allows for the detection of any biotinylated molecule, generating light grey-to-black spots that are visible to the naked eye and can be scanned with the Gentel Proteomics Multi-System.
Gentel president and CEO Alex Vodenlich said that RayBiotech’s collection of high-density, mid-density, and quantitative antibody arrays works seamlessly with their available ELISAs and antibody pairs to form a complete biomarker and proteomics workflow from hypothesis generation to validation.
RayBiotech’s arrays enable investigators in their biomedical research, biomarker and drug discovery and development.